These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 28787742

  • 21. Nasal obstruction and rhinorrhea reflect nonspecific nasal hyper-reactivity as evaluated by cold dry air provocation.
    Kim YH, Jang TY.
    Acta Otolaryngol; 2012 Oct; 132(10):1095-101. PubMed ID: 22668070
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [The influence of cold dry air on nasal mucosa].
    Huang YR, Lou HF, Zhang L.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan 05; 32(1):71-76. PubMed ID: 29798215
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA.
    Curr Med Res Opin; 2007 Oct 05; 23(10):2441-52. PubMed ID: 17723160
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
    Zhong Z, Xun Y, Shi X, Guan B, Wang M.
    Eur Arch Otorhinolaryngol; 2022 May 05; 279(5):2457-2464. PubMed ID: 34415405
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment.
    Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, Philpot EE.
    Allergy Asthma Proc; 2009 May 05; 30(2):120-7. PubMed ID: 19463202
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge.
    Jankowski R, Philip G, Togias A, Naclerio R.
    Rhinology; 1993 Sep 05; 31(3):97-100. PubMed ID: 8256085
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis.
    Arikan OK, Koc C, Kendi T, Muluk NB, Ekici A.
    Acta Otolaryngol; 2006 Jan 05; 126(1):37-42. PubMed ID: 16308253
    [Abstract] [Full Text] [Related]

  • 40. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
    Herman D, Garay R, Le Gal M.
    Int J Pediatr Otorhinolaryngol; 1997 Feb 14; 39(1):1-8. PubMed ID: 9051434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.